Paul J. Hesketh

18.6k total citations · 9 hit papers
161 papers, 11.5k citations indexed

About

Paul J. Hesketh is a scholar working on Surgery, Physiology and Oncology. According to data from OpenAlex, Paul J. Hesketh has authored 161 papers receiving a total of 11.5k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Surgery, 47 papers in Physiology and 43 papers in Oncology. Recurrent topics in Paul J. Hesketh's work include Nausea and vomiting management (105 papers), Anesthesia and Pain Management (64 papers) and Pathogenesis and Treatment of Hiccups (35 papers). Paul J. Hesketh is often cited by papers focused on Nausea and vomiting management (105 papers), Anesthesia and Pain Management (64 papers) and Pathogenesis and Treatment of Hiccups (35 papers). Paul J. Hesketh collaborates with scholars based in United States, Canada and Germany. Paul J. Hesketh's co-authors include Steven M. Grunberg, Richard J. Gralla, Mark G. Kris, Rebecca Clark-Snow, Fausto Roila, Jørn Herrstedt, David R. Gandara, Matti Aapro, David Warr and Mark R. Somerfield and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Paul J. Hesketh

158 papers receiving 11.0k citations

Hit Papers

Antiemetics: American Soc... 1999 2026 2008 2017 2011 2003 2008 2006 1999 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
    2011 827 citations Ethan Basch, Ann Alexis Prestrud et al. Journal of Clinical Oncology profile →
  2. The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin—The Aprepitant Protocol 052 Study Group
    2003 593 citations Paul J. Hesketh, Steven M. Grunberg et al. Journal of Clinical Oncology profile →
  3. Chemotherapy-Induced Nausea and Vomiting
    2008 587 citations Paul J. Hesketh profile →
  4. American Society of Clinical Oncology Guideline for Antiemetics in Oncology: Update 2006
    2006 516 citations Mark G. Kris, Paul J. Hesketh et al. Journal of Clinical Oncology profile →
  5. Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines
    1999 483 citations Richard J. Gralla, Mark G. Kris et al. Journal of Clinical Oncology profile →
  6. Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
    2017 471 citations Nasser H. Hanna, David H. Johnson et al. Journal of Clinical Oncology profile →
  7. Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
    2017 397 citations Paul J. Hesketh, Mark G. Kris et al. Journal of Clinical Oncology profile →
  8. 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients
    2016 397 citations Jørn Herrstedt, Matti Aapro et al. profile →
  9. Antiemetics: ASCO Guideline Update
    2020 224 citations Paul J. Hesketh, Mark G. Kris et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul J. Hesketh United States 51 8.3k 3.9k 2.4k 1.6k 1.4k 161 11.5k
Steven M. Grunberg United States 50 5.8k 0.7× 3.1k 0.8× 2.2k 0.9× 1.5k 0.9× 986 0.7× 156 9.9k
Fausto Roila Italy 45 4.5k 0.5× 2.0k 0.5× 1.7k 0.7× 980 0.6× 1.2k 0.8× 135 7.9k
Richard J. Gralla United States 64 6.8k 0.8× 3.1k 0.8× 6.8k 2.8× 5.6k 3.4× 1.6k 1.1× 294 16.2k
David Warr Canada 41 3.2k 0.4× 1.6k 0.4× 2.0k 0.8× 936 0.6× 1.0k 0.7× 103 6.4k
Rudolph M. Navari United States 42 3.7k 0.4× 2.1k 0.5× 893 0.4× 341 0.2× 762 0.5× 164 5.7k
Karin Jordan Germany 33 2.0k 0.2× 961 0.2× 4.1k 1.7× 1.4k 0.8× 606 0.4× 112 7.4k
Theodore F. Reiss United States 41 1.3k 0.2× 4.9k 1.3× 1.8k 0.8× 3.7k 2.3× 420 0.3× 105 8.9k
Carlo DeAngelis Canada 34 1.4k 0.2× 528 0.1× 1.4k 0.6× 608 0.4× 528 0.4× 205 4.1k
Joanne Mortimer United States 47 2.0k 0.2× 632 0.2× 4.4k 1.8× 3.0k 1.8× 409 0.3× 260 9.5k
Barry Laird United Kingdom 39 684 0.1× 1.9k 0.5× 1.8k 0.7× 657 0.4× 562 0.4× 139 4.3k

Countries citing papers authored by Paul J. Hesketh

Since Specialization
Citations

This map shows the geographic impact of Paul J. Hesketh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul J. Hesketh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul J. Hesketh more than expected).

Fields of papers citing papers by Paul J. Hesketh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul J. Hesketh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul J. Hesketh. The network helps show where Paul J. Hesketh may publish in the future.

Co-authorship network of co-authors of Paul J. Hesketh

This figure shows the co-authorship network connecting the top 25 collaborators of Paul J. Hesketh. A scholar is included among the top collaborators of Paul J. Hesketh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul J. Hesketh. Paul J. Hesketh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Jordan, Karin, Alexandre Chan, Richard J. Gralla, et al.. (2023). Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents—updated MASCC/ESMO consensus recommendation. Supportive Care in Cancer. 32(1). 53–53. 12 indexed citations
3.
Schwartzberg, Lee S., Hirotoshi Iihara, Matti Aapro, et al.. (2023). 2023 updated MASCC/ESMO Consensus recommendations: Prevention of nausea and vomiting following moderately emetic risk antineoplastic agents. Supportive Care in Cancer. 32(1). 45–45. 9 indexed citations
4.
Goldberg, Michael E., Meagan Montesion, Lauren Young, et al.. (2018). Multiple configurations of EGFR exon 20 resistance mutations after first- and third-generation EGFR TKI treatment affect treatment options in NSCLC. PLoS ONE. 13(11). e0208097–e0208097. 15 indexed citations
5.
Hanna, Nasser H., David H. Johnson, Sarah Temin, et al.. (2017). Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. Journal of Clinical Oncology. 35(30). 3484–3515. 471 indexed citations breakdown →
6.
McKee, Brady J., Andrea B. McKee, Sebastian Flacke, et al.. (2013). Initial Experience With a Free, High-Volume, Low-Dose CT Lung Cancer Screening Program. Journal of the American College of Radiology. 10(8). 586–592. 55 indexed citations
7.
8.
Basch, Ethan, Ann Alexis Prestrud, Paul J. Hesketh, et al.. (2011). Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update. Journal of Clinical Oncology. 29(31). 4189–4198. 827 indexed citations breakdown →
9.
Blanchard, Elizabeth, James Moon, Paul J. Hesketh, et al.. (2010). Comparison of Platinum-Based Chemotherapy in Patients Older and Younger than 70 Years: An Analysis of Southwest Oncology Group Trials 9308 and 9509. Journal of Thoracic Oncology. 6(1). 115–120. 36 indexed citations
10.
Kris, Mark G., Maurizio Tonato, Emilio Bria, et al.. (2010). Consensus recommendations for the prevention of vomiting and nausea following high-emetic-risk chemotherapy. Supportive Care in Cancer. 19(S1). 25–32. 27 indexed citations
11.
Safran, Howard, David A. Iannitti, Ramesh K. Ramanathan, et al.. (2004). Herceptin and Gemcitabine for Metastatic Pancreatic Cancers That Overexpress HER-2/neu. Cancer Investigation. 22(5). 706–712. 142 indexed citations
12.
Horgan, Kevin, Steven M. Grunberg, Paul J. Hesketh, et al.. (2003). 945 Analysis of pooled data from two Phase III studies of the NK-1 antagonist aprepitant to assess relationships between the incidence and control of cisplatin-induced acute vomiting and delayed vomiting. European Journal of Cancer Supplements. 1(5). S284–S285. 5 indexed citations
13.
Hesketh, Paul J., et al.. (2000). Control of high-dose-cisplatin-induced emesis with an all-oral three-drug antiemetic regimen. Supportive Care in Cancer. 8(1). 46–48. 4 indexed citations
14.
Safran, Howard, Harry Wanebo, Paul J. Hesketh, et al.. (2000). Paclitaxel and concurrent radiation for gastric cancer. International Journal of Radiation Oncology*Biology*Physics. 46(4). 889–894. 26 indexed citations
15.
Hesketh, Paul J., Richard J. Gralla, Andreas du Bois, & Maurizio Tonato. (1998). Methodology of antiemetic trials: response assessment, evaluation of new agents and definition of chemotherapy emetogenicity. Supportive Care in Cancer. 6(3). 221–227. 44 indexed citations
16.
Tavorath, Ranjana & Paul J. Hesketh. (1996). Drug Treatment of Chemotherapy-Induced Delayed Emesis. Drugs. 52(5). 639–648. 103 indexed citations
17.
18.
Emri, Salïh, et al.. (1994). Treatment of Malignant Pleural Mesothelioma with Cisplatin, Mitomycin C and Alpha Interferon. Oncology. 51(4). 348–351. 33 indexed citations
19.
Hesketh, Paul J., et al.. (1993). Treatment of advanced non-small cell lung cancer with very high-dose cisplatin combined with etoposide and mitomycin C. Cancer. 71(3). 717–720. 4 indexed citations
20.
Hainsworth, John D. & Paul J. Hesketh. (1992). Single-dose ondansetron for the prevention of cisplatin-induced emesis: efficacy results.. PubMed. 19(6 Suppl 15). 14–9. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steven M. Grunberg Breakdown of academic impact, for papers by Fausto Roila Breakdown of academic impact, for papers by Richard J. Gralla Breakdown of academic impact, for papers by David Warr Breakdown of academic impact, for papers by Rudolph M. Navari Breakdown of academic impact, for papers by Karin Jordan Breakdown of academic impact, for papers by Theodore F. Reiss Breakdown of academic impact, for papers by Carlo DeAngelis Breakdown of academic impact, for papers by Joanne Mortimer Breakdown of academic impact, for papers by Barry Laird
Rankless by CCL
2026